Selected research
Market Outlook & Growth Opportunities
Global Desflurane Market Outlook and Growth Opportunities 2026
Market perspective
The global Desflurane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Desflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Desflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Desflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Desflurane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Desflurane market include Baxter Limited and Hengrui Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Desflurane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Desflurane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Desflurane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Desflurane market size, projected growth trends, production technologies, key applications, and end-use industries.
Desflurane Segment by Company
Baxter Limited
Hengrui Pharmaceuticals
Desflurane Segment by Type
240ml
250ml
Desflurane Segment by Application
Hospital
Clinic
Others
Desflurane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Desflurane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Desflurane market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Desflurane significant trends, drivers, influence factors in global and regions.
6. To analyze Desflurane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Desflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desflurane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Desflurane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Desflurane industry.
Chapter 3: Detailed analysis of Desflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Desflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Desflurane in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 240ml
- 250ml
Applications
- Hospital
- Clinic
- Others
Companies covered
- Baxter Limited
- Hengrui Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Desflurane Sales Value (2021-2032)
- 1.2.2 Global Desflurane Sales Volume (2021-2032)
- 1.2.3 Global Desflurane Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Desflurane Market Dynamics
- 2.1 Desflurane Industry Trends
- 2.2 Desflurane Industry Drivers
- 2.3 Desflurane Industry Opportunities and Challenges
- 2.4 Desflurane Industry Restraints
3 Desflurane Market by Company
- 3.1 Global Desflurane Company Revenue Ranking in 2025
- 3.2 Global Desflurane Revenue by Company (2021-2026)
- 3.3 Global Desflurane Sales Volume by Company (2021-2026)
- 3.4 Global Desflurane Average Price by Company (2021-2026)
- 3.5 Global Desflurane Company Ranking (2024-2026)
- 3.6 Global Desflurane Company Manufacturing Base and Headquarters
- 3.7 Global Desflurane Company Product Type and Application
- 3.8 Global Desflurane Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Desflurane Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Desflurane Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Desflurane Market by Type
- 4.1 Desflurane Type Introduction
- 4.1.1 240ml
- 4.1.2 250ml
- 4.2 Global Desflurane Sales Volume by Type
- 4.2.1 Global Desflurane Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Desflurane Sales Volume by Type (2021-2032)
- 4.2.3 Global Desflurane Sales Volume Share by Type (2021-2032)
- 4.3 Global Desflurane Sales Value by Type
- 4.3.1 Global Desflurane Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Desflurane Sales Value by Type (2021-2032)
- 4.3.3 Global Desflurane Sales Value Share by Type (2021-2032)
5 Desflurane Market by Application
- 5.1 Desflurane Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Desflurane Sales Volume by Application
- 5.2.1 Global Desflurane Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Desflurane Sales Volume by Application (2021-2032)
- 5.2.3 Global Desflurane Sales Volume Share by Application (2021-2032)
- 5.3 Global Desflurane Sales Value by Application
- 5.3.1 Global Desflurane Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Desflurane Sales Value by Application (2021-2032)
- 5.3.3 Global Desflurane Sales Value Share by Application (2021-2032)
6 Desflurane Regional Sales and Value Analysis
- 6.1 Global Desflurane Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Desflurane Sales by Region (2021-2032)
- 6.2.1 Global Desflurane Sales by Region: 2021-2026
- 6.2.2 Global Desflurane Sales by Region (2027-2032)
- 6.3 Global Desflurane Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Desflurane Sales Value by Region (2021-2032)
- 6.4.1 Global Desflurane Sales Value by Region: 2021-2026
- 6.4.2 Global Desflurane Sales Value by Region (2027-2032)
- 6.5 Global Desflurane Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Desflurane Sales Value (2021-2032)
- 6.6.2 North America Desflurane Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Desflurane Sales Value (2021-2032)
- 6.7.2 Europe Desflurane Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Desflurane Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Desflurane Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Desflurane Sales Value (2021-2032)
- 6.9.2 South America Desflurane Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Desflurane Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Desflurane Sales Value Share by Country, 2025 VS 2032
7 Desflurane Country-level Sales and Value Analysis
- 7.1 Global Desflurane Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Desflurane Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Desflurane Sales by Country (2021-2032)
- 7.3.1 Global Desflurane Sales by Country (2021-2026)
- 7.3.2 Global Desflurane Sales by Country (2027-2032)
- 7.4 Global Desflurane Sales Value by Country (2021-2032)
- 7.4.1 Global Desflurane Sales Value by Country (2021-2026)
- 7.4.2 Global Desflurane Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Desflurane Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Desflurane Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Desflurane Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Desflurane Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Desflurane Sales Value Growth Rate (2021-2032)
- 7.9.2 France Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Desflurane Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Desflurane Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Desflurane Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Desflurane Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Desflurane Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Desflurane Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Desflurane Sales Value Growth Rate (2021-2032)
- 7.16.2 China Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Desflurane Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Desflurane Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Desflurane Sales Value Growth Rate (2021-2032)
- 7.19.2 India Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Desflurane Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Desflurane Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Desflurane Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Desflurane Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Desflurane Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Desflurane Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Desflurane Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Desflurane Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Desflurane Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Desflurane Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Desflurane Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Desflurane Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Desflurane Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Desflurane Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Desflurane Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Desflurane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Baxter Limited
- 8.1.1 Baxter Limited Company Information
- 8.1.2 Baxter Limited Business Overview
- 8.1.3 Baxter Limited Desflurane Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Baxter Limited Desflurane Product Portfolio
- 8.1.5 Baxter Limited Recent Developments
- 8.2 Hengrui Pharmaceuticals
- 8.2.1 Hengrui Pharmaceuticals Company Information
- 8.2.2 Hengrui Pharmaceuticals Business Overview
- 8.2.3 Hengrui Pharmaceuticals Desflurane Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Hengrui Pharmaceuticals Desflurane Product Portfolio
- 8.2.5 Hengrui Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Desflurane Value Chain Analysis
- 9.1.1 Desflurane Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Desflurane Sales Mode & Process
- 9.2 Desflurane Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Desflurane Distributors
- 9.2.3 Desflurane Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst